Sociedad Americana de Hirudoterapia

Tunneling of a leech into a free flap breast reconstruction

Case report published in JPRAS (2011)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportSeguridad y control de infeccionesFlurry M et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2011

Abstract

Leeches are well known to migrate over the surface of the treated tissues. At times, they can be located in remote locations once they become engorged and detach. We report the first case of a leech tunneling through a dermal bite wound on a breast free flap.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAdultAnimalsCarcinoma, Ductal, BreastDilatation, PathologicFemaleHirudo medicinalisHumansHyperemiaLeechingMammaplastySurgical Flaps

Resumen

First reported case of leech tunneling through a dermal bite wound on a free flap breast reconstruction. Highlights migration risk after engorgement and detachment.

Por qué esto importa para la hirudoterapia

This case report describes what the authors state is the first documented case of a medicinal leech tunneling through a dermal bite wound into a breast free flap reconstruction, noting that leeches are known to migrate over treated tissue surfaces and can detach in remote locations once engorged. The report is directly relevant to hirudotherapy practice as it highlights an unusual but potentially serious mechanical complication of leech application. The limitation is that this is a single case report with no comparative or incidence data, and the abstract provides minimal clinical detail about management or outcomes.

Citación

Tunneling of a leech into a free flap breast reconstruction.

Flurry M et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2011

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 26, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.